GeneDx Holdings Corp.
WGS
$107.20
-$1.15-1.06%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 357.20M | 326.81M | 302.16M | 263.18M | 237.71M |
| Total Other Revenue | 5.13M | 3.33M | 3.29M | 4.05M | 5.95M |
| Total Revenue | 362.32M | 330.14M | 305.45M | 267.23M | 243.66M |
| Cost of Revenue | 118.90M | 114.68M | 111.00M | 108.23M | 108.20M |
| Gross Profit | 243.42M | 215.47M | 194.45M | 159.00M | 135.46M |
| SG&A Expenses | 183.96M | 179.73M | 168.78M | 164.27M | 163.96M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1.56M | 1.56M | 1.56M | 1.46M | 2.47M |
| Total Operating Expenses | 355.18M | 342.54M | 326.91M | 317.17M | 320.45M |
| Operating Income | 7.14M | -12.40M | -21.46M | -49.94M | -76.80M |
| Income Before Tax | 1.54M | -38.39M | -52.63M | -84.23M | -118.33M |
| Income Tax Expenses | 130.00K | 186.00K | -343.00K | -730.00K | -855.00K |
| Earnings from Continuing Operations | 1.41 | -38.58 | -52.29 | -83.50 | -117.47 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.41M | -38.58M | -52.29M | -83.50M | -117.47M |
| EBIT | 7.14M | -12.40M | -21.46M | -49.94M | -76.80M |
| EBITDA | 29.60M | 9.08M | -408.00K | -23.65M | -47.77M |
| EPS Basic | 0.04 | -1.44 | -1.98 | -3.17 | -4.51 |
| Normalized Basic EPS | 0.37 | -0.57 | -0.92 | -1.79 | -2.40 |
| EPS Diluted | 0.02 | -1.44 | -1.99 | -3.18 | -4.51 |
| Normalized Diluted EPS | 0.36 | -0.57 | -0.92 | -1.79 | -2.40 |
| Average Basic Shares Outstanding | 111.61M | 109.65M | 107.56M | 105.69M | 104.38M |
| Average Diluted Shares Outstanding | 112.78M | 109.65M | 107.56M | 105.69M | 104.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |